XML 51 R42.htm IDEA: XBRL DOCUMENT

Non-controlling Interest (Tables)

9 Months Ended

Sep. 30, 2025

Noncontrolling Interest [Abstract]

Schedule Of Approximate Interests In Certain Consolidated Subsidiaries

Non-controlling interest recorded in our condensed consolidated financial statements as of September 30, 2025 and December 31, 2024, relates to the following approximate interests in certain consolidated subsidiaries, which we do not own.


		September 30, 2025				December 31, 2024
MiNK Therapeutics, Inc.			0	%			45	%
SaponiQx, Inc.			30	%			30	%

Schedule Of Changes In Non-controlling Interest

Changes in non-controlling interest for the periods ended September 30, 2025 and December 31, 2024, were as follows (in thousands):


		September 30, 2025				December 31, 2024
Beginning balance		$	19,956			$	11,949

Net loss attributable to non-controlling interest			(3,164	)			(5,059	)

Other items:
Deconsolidation of a subsidiary			(25,037	)			—
Sale of subsidiary shares in private placement			—				10,234
Issuance of subsidiary shares for employee stock purchase plan and exercise of options			1				20
Subsidiary share-based compensation			1,513				2,812
Total other items			(23,523	)			13,066

Ending balance		$	(6,731	)		$	19,956

Deconsolidation of a subsidiary

In the quarter ended September 30, 2025, we deconsolidated MiNK and derecognized the associated non-controlling interest balance.